Form D · Other Technology

Biopharmaceutical Research Co

Castroville, CA · CIK 0001826834

Offering snapshot reported Aug 9, 2023 · SEC filing

Reported sold
$676K
Offering amount: $676K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 7, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 9, 2023Initial$676,065No comparison1SEC filing
Jun 20, 2023Amendment$23,156,923$12,964,107vs Jul 14, 202236SEC filing
Jul 14, 2022Initial$10,192,816No comparison31SEC filing
Mar 18, 2022Amendment$2,535,500$1,125,500vs Feb 17, 202222SEC filing
Feb 17, 2022Initial$1,410,000No comparison19SEC filing
Dec 20, 2021Initial$85,876No comparison1SEC filing
Oct 2, 2020Initial$2,045,000No comparison17SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-489227

Source: Form D, filed Aug 9, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Edward Howard Goodwin Director
George Bennett Hodgin Director, Executive
Osagie Imasogie Director
Charles Schumacher Director
David Weinmann Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
11045 Commercial Parkway
Castroville, CA, 95012